Endocrinology, Diabetes & Metabolism Case Reports (Sep 2022)

Thyrotropinoma with silent somatotroph and lactotroph adenoma during pregnancy

  • Yu-Fang Wu,
  • Hui Yi Ng,
  • Divya Namboodiri,
  • David Lewis,
  • Andrew Davidson,
  • Bernard Champion,
  • Veronica Preda

DOI
https://doi.org/10.1530/EDM-21-0194
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 6

Abstract

Read online

Thyrotropinomas are an uncommon cause of hyperthyroidism and are exceedingly rarely identified during pregnancy, with limited evidence to guide management. Most commonly they present as macroadenomas and may cause symptoms of mass effect including headache, visual field defects and hypopituitarism. We present a case of a 35-year-old woman investigated for headaches in whom a 13 mm thyrotropinoma was found. In the lead-up to planned trans-sphenoidal surgery (TSS), she spontaneously conceived and surgery was deferred, as was pharmacotherapy, at her request. The patient was closely monitored through her pregnancy by a multi-disciplinary team and delivered without complication. Pituitary surgery was performed 6 months post-partum. Isolated secondary hypothyroidism was diagnosed postoperatively and replacement thyroxine was commenced. Histopathology showed a double lesion with predominant pituitary transcription factor-1 positive, steroidogenic factor negative plurihormonal adenoma and co-existent mixed thyroid-stimulating hormone, growth hormone, lactotroph and follicle-stimulating hormone staining with a Ki-67 of 1%. This case demonstrates a conservative approach to thyrotropinoma in pregnancy with a successful outcome. This highlights the need to consider the timing of intervention with careful consideration of risks to mother and fetus.